sales@targetmol.com (US) / info@targetmol.com    Tel: (781) 999-4286 / (781) 999-5354
Home > c-Kit
c-Kit
Cat.No. Product Name Information Area
T4332 DCC-2618 DCC-2618 is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM). Others
T3452 ISCK03 ISCK03 is a selective SCF/c-Kit inhibitor. Immunology
T6930 Pazopanib HCl (GW786034 HCl) Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectiv... Cancer
T2624 OSI-930 OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth fact... Cancer
T2620 G-749 G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the ... Cardiovascular System
T2609 Masitinib Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in... Cancer
T2582 Apatinib Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In add... Cancer
T2516 Amuvatinib(MP470) Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineop... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of... Cancer
T2446 KI8751 KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM. Cancer
T2115 Pexidartinib Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine k... Cancer
T2070 CEP-32496 CEP-32496 is a highly potent inhibitor of BRAF. Other
T1925 PLX647 PLX647 is a highly selective dual FMS/KIT kinase inhibitor (IC50: 28/16 nM). Cancer
T1830 BX795 BX795 is an effective and selective PDK1 inhibitor (IC50: 6 nM), and its selectivity ... Other
T1667 Tandutinib Tandutinib (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also ... Cancer
T1621 Imatinib Mesylate Imatinib mesylate is a specific tyrosine kinase receptor inhibitor with antineoplasti... Cancer
T1452 Axitinib Axitinib is an orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the p...
T1448 Dasatinibhot Dasatinib Anhydrous is an orally bioavailable synthetic small molecule-inhibitor of S... Cancer
T0374L Sunitinib Sunitinib, a multi-targeted RTK inhibitor, is targeting PDGFRβ and VEGFR2 (Flk-1) wit... Cancer
T0374 Sunitinib Malate Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosi... Cancer
1